Qiao Bobo, PhD FDA

LCDR Qiao Y. Bobo, PhD currently serves as an acting team lead in the Division of Manufacturing and Product Quality (DMPQ), Office of Compliance and Biologics Quality, Center for Biologics Evaluation and Research at the U.S. Food and Drug Administration. She oversees the review of submissions and inspection of biological drug/vaccine manufacturing facilities in the United States and overseas. Prior to her position as an acting team lead, Dr. Bobo was a reviewer and lead inspector in DMPQ. Dr. Bobo also led advisory meetings with industry representatives to recommend actions related to facility design, operation and manufacturing. Prior to joining FDA, Dr. Bobo had more than a decade of experience in the field of vaccine development and gene therapy with biopharmaceutical companies, publishing multiple peer reviewed articles. Dr. Bobo received her PhD in Cell and Molecular Biology from the University of Vermont.